Study on rare heart muscle diseases using advanced MRI
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Skin clinical trials.
This study uses a special heart MRI to better diagnose and understand rare heart muscle diseases. It may help doctors predict risks and make more accurate treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a heart MRI since 2010
- Your doctor suspects you have a rare heart muscle disease
- You do not have a severe irregular heartbeat
- You do not have severe heart valve disease
- You agree to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at people with cardiomyopathy to understand which patients are most in need of a heart transplant. By joining, you will help doctors learn more about critical cases and improve care for heart muscle disease.
This study tests different heart scans to find heart amyloidosis, a condition where abnormal proteins build up in the heart, in people who have certain warning signs. The goal is to see which test works best to help diagnose it faster.
This study uses heart MRI scans to learn more about cardiovascular health in adults. If you are 18 or older and have been referred for a heart MRI at Montefiore, you may be able to join.
This study collects information over time from people with different types of cardiomyopathy (a disease of the heart muscle). By tracking your health, doctors hope to learn more about these conditions and improve future care.
This trial uses a heart MRI to measure details in people with dilated cardiomyopathy and reduced pumping strength. It aims to use these MRI findings to better predict your future heart risk and guide care.
This study uses heart MRI to find people with early signs of heart muscle disease who still have normal-sized heart chambers. It aims to better predict who is at risk so they can get earlier care.
Hear when a new Danon Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.